Brief: Cytek Biosciences Shares Open 18.2% Above IPO Price In Nasdaq Debut
23/07/2021 17:08
July 23 (Reuters) -
* CYTEK BIOSCIENCES SHARES OPEN AT $20.10 IN NASDAQ DEBUT
VERSUS
IPO PRICE OF $17/SHARE
Further company coverage: CTKB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million